In Brief: Bristol-Myers Squibb
Executive Summary
Bristol-Myers Squibb: Donald Hayden, who had headed the company's oncology/immunology business, to senior VP-worldwide franchise management and business development, reporting to BMS Pharmaceutical Group President Kenneth Weg. Michael Loberg, PhD, most recently U.S. Pharmaceutical Group senior VP, assumes Hayden's most recent responsibilities as president of the Oncology/Immunology Division...